First Time Loading...

Japan Animal Referral Medical Center Co Ltd
TSE:6039

Watchlist Manager
Japan Animal Referral Medical Center Co Ltd Logo
Japan Animal Referral Medical Center Co Ltd
TSE:6039
Watchlist
Price: 1 976 JPY -0.2% Market Closed
Updated: May 17, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

8.5B
-2%
Assets
Growth Rates:
1 Year
+5%
3 Years
+46%
5 Years
+39%
7 Years
+70%
10 Years
-
4.6B
-4%
Liabilities
Growth Rates:
1 Year
+3%
3 Years
+29%
5 Years
+7%
7 Years
+21%
10 Years
-
3.9B
+1%
Equity
Growth Rates:
1 Year
+8%
3 Years
+73%
5 Years
+117%
7 Years
+230%
10 Years
-

Balance Sheet Decomposition
Japan Animal Referral Medical Center Co Ltd

8.5B
Assets
4.6B
Liabilities
8.5B
Assets
4.6B
Liabilities
Current Assets 1.9B
Cash & Short-Term Investments 1.5B
Receivables 266m
Other Current Assets 157m
Non-Current Assets 6.6B
PP&E 5.8B
Intangibles 564.6m
Other Non-Current Assets 288.6m
Current Liabilities 1.1B
Accounts Payable 70.8m
Accrued Liabilities 54.8m
Other Current Liabilities 924.8m
Non-Current Liabilities 3.6B
Long-Term Debt 3.4B
Other Non-Current Liabilities 187.1m

Balance Sheet
Japan Animal Referral Medical Center Co Ltd

Rotate your device to view
Balance Sheet
Currency: JPY
Mar-2014 Mar-2015 Mar-2016 Mar-2017 Mar-2018 Mar-2019 Mar-2020 Mar-2021 Mar-2022 Mar-2023
Assets
Cash & Cash Equivalents
457
733
850
858
890
1 250
1 249
1 215
1 069
1 916
Cash Equivalents
457
733
850
858
890
1 250
1 249
1 215
1 069
1 916
Total Receivables
85
78
100
99
111
133
133
139
221
254
Accounts Receivables
85
78
100
99
111
133
133
139
221
254
Other Receivables
0
0
0
0
0
0
0
0
0
0
Inventory
28
30
36
44
47
49
53
63
129
127
Other Current Assets
12
42
67
100
106
49
29
41
121
100
Total Current Assets
581
884
1 053
1 102
1 154
1 480
1 465
1 458
1 540
2 397
PP&E Net
2 563
2 974
3 026
3 932
4 553
4 430
4 283
4 199
4 709
5 333
PP&E Gross
2 563
2 974
3 026
3 932
4 553
4 430
4 283
4 199
0
5 333
Accumulated Depreciation
1 546
1 711
1 794
1 678
1 826
2 037
2 083
2 200
0
2 723
Intangible Assets
41
34
23
28
24
8
21
14
462
425
Goodwill
0
0
0
0
0
0
0
0
204
183
Other Long-Term Assets
38
30
59
65
201
170
161
173
193
241
Other Assets
0
0
0
0
0
0
0
0
204
183
Total Assets
3 224
N/A
3 922
+22%
4 161
+6%
5 126
+23%
5 933
+16%
6 088
+3%
5 929
-3%
5 844
-1%
7 108
+22%
8 579
+21%
Liabilities
Accounts Payable
31
30
40
48
46
40
50
48
66
83
Accrued Liabilities
13
10
42
57
43
55
55
67
79
87
Short-Term Debt
0
210
0
650
0
0
0
0
0
0
Current Portion of Long-Term Debt
425
618
611
829
495
522
511
549
546
583
Other Current Liabilities
106
181
147
144
152
273
224
250
274
517
Total Current Liabilities
575
1 049
840
1 728
736
890
841
915
966
1 270
Long-Term Debt
2 235
2 171
2 298
2 130
3 616
3 312
2 893
2 526
3 376
3 393
Deferred Income Tax
9
0
0
0
0
0
0
0
166
118
Other Liabilities
43
44
27
40
52
57
61
68
91
92
Total Liabilities
2 862
N/A
3 266
+14%
3 165
-3%
3 897
+23%
4 405
+13%
4 259
-3%
3 795
-11%
3 508
-8%
4 598
+31%
4 873
+6%
Equity
Common Stock
200
269
332
333
379
382
385
386
386
791
Retained Earnings
7
163
377
607
815
1 110
1 423
1 708
1 995
2 375
Additional Paid In Capital
155
224
287
288
334
337
340
333
316
711
Treasury Stock
0
0
0
0
0
0
14
90
186
172
Other Equity
0
0
0
0
0
0
0
0
0
0
Total Equity
362
N/A
656
+81%
996
+52%
1 228
+23%
1 528
+24%
1 829
+20%
2 134
+17%
2 336
+9%
2 510
+7%
3 706
+48%
Total Liabilities & Equity
3 224
N/A
3 922
+22%
4 161
+6%
5 126
+23%
5 933
+16%
6 088
+3%
5 929
-3%
5 844
-1%
7 108
+22%
8 579
+21%
Shares Outstanding
Common Shares Outstanding
1
2
2
2
2
2
2
2
2
3
Preferred Shares Outstanding
1
0
0
0
0
0
0
0
0
0

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 138,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.